Bonita David P

Average Profitability
<0.0001%
Insider Buys Quantity
14
Insider Buys Sum
$106.58M
Insider Sells Quantity
13
Insider Sells Sum
$4.19M

Insider Activity of Bonita David P

The largest purchase of all time was on 2020-09-25 and amounted to 2473600 shares of Prelude Therapeutics Incorporated for $47M.

The largest sale of all time was on 2021-08-17 and amounted to 34796 shares of Repare Therapeutics Inc. for $1.19M.

Biography of Bonita David P

No biography is available at this moment.

2023-05-22PurchasePrelude Therapeutics Incorporated
PRLD
869,565
1.9148%
$5.75$5M-30.71%
2022-09-19PurchaseThird Harmonic Bio, Inc.
THRD
300,000
0.887%
$17.00$5.1M-70.12%
2022-06-22PurchaseIkena Oncology, Inc.
IKNA
23,419
0.0656%
$3.71$86,884+14.75%
2021-09-07SaleRepare Therapeutics Inc.
RPTX
director
887
0.0026%
$33.93$30,096-53.56%
2021-09-03SaleRepare Therapeutics Inc.
RPTX
director
7,197
0.0195%
$34.00$244,698-56.83%
2021-09-02SaleRepare Therapeutics Inc.
RPTX
director
16,424
0.0438%
$34.24$562,358-57.79%
2021-09-01SaleRepare Therapeutics Inc.
RPTX
director
12,968
0.035%
$33.98$440,653-56.98%
2021-08-31SaleRepare Therapeutics Inc.
RPTX
director
8,472
0.0228%
$33.94$287,540-56.97%
2021-08-30SaleRepare Therapeutics Inc.
RPTX
director
6,697
0.0183%
$33.92$227,162-56.25%
2021-08-27SaleRepare Therapeutics Inc.
RPTX
director
7,093
0.0192%
$33.94$240,736-56.49%
2021-08-26SaleRepare Therapeutics Inc.
RPTX
director
4,283
0.0121%
$34.52$147,849-55.38%
2021-08-25SaleRepare Therapeutics Inc.
RPTX
director
7,082
0.0188%
$34.34$243,196-57.68%
2021-08-24SaleRepare Therapeutics Inc.
RPTX
director
4,039
0.0109%
$34.07$137,609-56.56%
2021-08-23SaleRepare Therapeutics Inc.
RPTX
director
7,094
0.0192%
$34.06$241,622-56.26%
2021-08-18SaleRepare Therapeutics Inc.
RPTX
director
5,860
0.016%
$33.99$199,181-55.78%
2021-08-17SaleRepare Therapeutics Inc.
RPTX
director
34,796
0.0937%
$34.12$1.19M-56.42%
2021-03-30PurchaseIkena Oncology, Inc.
IKNA
director
423,400
6.8729%
$16.00$6.77M-49.34%
2021-01-11PurchasePrelude Therapeutics Incorporated
PRLD
83,400
–
$0$0-51.76%
2020-09-25PurchasePrelude Therapeutics Incorporated
PRLD
2.47M
56.1543%
$19.00$47M+48.63%
2020-08-21PurchasePrelude Therapeutics Incorporated
PRLD
2.07M
–
$0$0+4,277.78%
Total: 27
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.